Drug intelligence / Profile preview

blink tears

Development stage
Phase 4
Lead developer
Bausch + Lomb
Modality
Small Molecules
Administration
Ophthalmic
01

Overview

Blink Tears is an over-the-counter (OTC) lubricating ophthalmic solution used for the temporary relief of burning, irritation, and discomfort due to dryness of the eye or exposure to wind or sun. The formulation primarily contains polyethylene glycol 400 (0.4%) as a lubricant and humectant, which works by stabilizing the tear film and reducing ocular surface friction. It also incorporates sodium hyaluronate, a viscoelastic polymer that mimics the natural mucin layer of the eye to enhance moisture retention and provide prolonged comfort. Originally developed by Abbott Medical Optics (AMO), the brand was later acquired by Johnson & Johnson Vision Care and subsequently by Bausch + Lomb in 2023. It is frequently utilized to manage symptoms of mild to moderate dry eye disease and to improve ocular comfort following ophthalmic procedures such as cataract surgery.

Brand names
Blink TearsBlink Lubricating Eye Drops
Other names
Polyethylene glycol 400 0.4% ophthalmic solutionPEG 400 0.4% ophthalmic solutionISTA Tears

Beyond the preview

Go deeper on blink tears.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on blink tears.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call